Brevibloc

In some countries, this medicine may only be approved for veterinary use.

In the US, Brevibloc (esmolol systemic) is a member of the following drug classes: cardioselective beta blockers, group II antiarrhythmics and is used to treat Atrial Fibrillation, Atrial Flutter, Intra- or Post-op SVT or Hypertension and Supraventricular Tachycardia.

US matches:

• Brevibloc

Ingredient matches for Brevibloc

Esmolol

Esmolol is reported as an ingredient of Brevibloc in the following countries:

• Italy


• Portugal


• Switzerland

Esmolol hydrochloride (a derivative of Esmolol) is reported as an ingredient of Brevibloc in the following countries:

• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Canada


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Netherlands


• New Zealand


• Norway


• Poland


• Spain


• Sweden


• Taiwan


• Turkey


• United Kingdom


• United States

International Drug Name Search